Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vs Sequential BCG and EMDA-MMC in High-Risk NMIBC
NCT03664869Phase 3Unknown
- Sponsor
- Turku University Hospital
- Start
- Oct 2018
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Turku University Hospital. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT03664869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664869.